Class information for:
Level 2: METFORMIN//ACARBOSE//GLIMEPIRIDE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
1662 6318 32.0 63%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 3)


ID, lev.
above		 Publications Label for level above
266 40530 DIABETES CARE//DIABETES EDUCATOR//DIABETIC MEDICINE

Classes in level below (level 1)


ID, lev. below Publications Label for level below
4998 1620 GLIMEPIRIDE//JTT 608//SECONDARY FAILURE
8937 1135 METFORMIN//LACTIC ACIDOSIS//METFORMIN ASSOCIATED LACTIC ACIDOSIS
9678 1065 ACARBOSE//ALPHA GLUCOSIDASE INHIBITOR//MIGLITOL
12075 869 ADVANCED OXIDATION PROTEIN PRODUCTS//ADVANCED OXIDATION PROTEIN PRODUCTS AOPP//AOPP
16644 578 METFORMIN HYDROCHLORIDE//PIOGLITAZONE HYDROCHLORIDE//ROSIGLITAZONE MALEATE
18682 474 INSULIN OVERDOSE//REACTIVE HYPOGLYCEMIA//BIOCHEMICAL HYPOGLYCEMIA
19245 449 NATEGLINIDE//KAD 1229//REPAGLINIDE
31066 128 GLICLAZIDE//INTERNAL MED DIABETOL CLIN PHARMACOL//DRUG QUAL CONTROL PHARMACOVIGILANC

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 METFORMIN Author keyword 148 20% 10% 651
2 ACARBOSE Author keyword 74 37% 3% 158
3 GLIMEPIRIDE Author keyword 72 44% 2% 126
4 REPAGLINIDE Author keyword 65 46% 2% 104
5 NATEGLINIDE Author keyword 64 53% 1% 85
6 GLICLAZIDE Author keyword 61 41% 2% 116
7 ALPHA GLUCOSIDASE INHIBITOR Author keyword 40 32% 2% 103
8 KAD 1229 Author keyword 34 93% 0% 13
9 MIGLITOL Author keyword 31 52% 1% 42
10 ALPHA GLUCOSIDASE Author keyword 26 17% 2% 144

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 METFORMIN 148 20% 10% 651 Search METFORMIN Search METFORMIN
2 ACARBOSE 74 37% 3% 158 Search ACARBOSE Search ACARBOSE
3 GLIMEPIRIDE 72 44% 2% 126 Search GLIMEPIRIDE Search GLIMEPIRIDE
4 REPAGLINIDE 65 46% 2% 104 Search REPAGLINIDE Search REPAGLINIDE
5 NATEGLINIDE 64 53% 1% 85 Search NATEGLINIDE Search NATEGLINIDE
6 GLICLAZIDE 61 41% 2% 116 Search GLICLAZIDE Search GLICLAZIDE
7 ALPHA GLUCOSIDASE INHIBITOR 40 32% 2% 103 Search ALPHA+GLUCOSIDASE+INHIBITOR Search ALPHA+GLUCOSIDASE+INHIBITOR
8 KAD 1229 34 93% 0% 13 Search KAD+1229 Search KAD+1229
9 MIGLITOL 31 52% 1% 42 Search MIGLITOL Search MIGLITOL
10 ALPHA GLUCOSIDASE 26 17% 2% 144 Search ALPHA+GLUCOSIDASE Search ALPHA+GLUCOSIDASE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ACARBOSE 92 37% 3% 200
2 SECONDARY FAILURE 57 57% 1% 68
3 GLIPIZIDE 56 53% 1% 74
4 GLIBENCLAMIDE 50 20% 3% 221
5 MEGLITINIDE ANALOGS 49 94% 0% 17
6 ALPHA GLUCOSIDASE INHIBITION 45 68% 1% 40
7 BIGUANIDES 44 56% 1% 53
8 A 4166 42 73% 1% 32
9 GLYBURIDE 41 31% 2% 111
10 SULFONYLUREAS 38 24% 2% 140

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Metformin and other antidiabetic agents in renal failure patients 2015 6 110 39%
Drug therapy - Metformin 1996 980 52 73%
Metformin in Patients With Type 2 Diabetes and Kidney Disease A Systematic Review 2014 12 66 86%
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency 2011 89 43 65%
Pharmacologic therapy for type 2 diabetes mellitus 1999 605 133 50%
Clinical Pharmacokinetics of Metformin 2011 158 80 36%
Metformin: An update 2002 444 93 52%
BIGUANIDES AND NIDDM 1992 395 107 82%
alpha-Glucosidase inhibitors for patients with type 2 diabetes - Results from a cochrane systematic review and meta-analysis 2005 156 47 89%
Metformin-Associated Lactic Acidosis 2015 1 38 74%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PHARMACEUT REGULATORY AFFAIRS QUAL ASSURANCE DE 4 75% 0.0% 3
2 INTERNAL MED DIABETOL CLIN PHARMACOL 3 43% 0.1% 6
3 HIGASHISONOGI TEA BRANCH 3 100% 0.0% 3
4 NAZL INFORMAZ TOSSICOL 3 100% 0.0% 3
5 FOOD BIOCHEMKITA KU 2 29% 0.1% 7
6 CLIN ANGIOL HYPERTENS DIABETOL 2 36% 0.1% 5
7 BEST CELLULAR NUTR 2 67% 0.0% 2
8 DEV PHARMACEUT SCI PL CHEM 2 67% 0.0% 2
9 GEN FOODS 2 67% 0.0% 2
10 INSECTICIDE 2 67% 0.0% 2

Related classes at same level (level 2)


Rank Relatedness score Related classes
1 0.0000018104 MOMORDICA CHARANTIA//4 HYDROXYISOLEUCINE//GYMNEMA SYLVESTRE
2 0.0000016761 METABOLIC SYNDROME//WAIST CIRCUMFERENCE//ABDOMINAL OBESITY
3 0.0000015902 DIABETES CARE//DIABETES EDUCATOR//DIABETES TECHNOLOGY & THERAPEUTICS
4 0.0000014781 PPAR GAMMA//PIOGLITAZONE//ROSIGLITAZONE
5 0.0000011375 INSULIN DEGRADING ENZYME//GLYCOSYLPHOSPHATIDYLINOSITOL//NEPRILYSIN
6 0.0000010020 ALPHA LIPOIC ACID//LIPOIC ACID//THIOCTIC ACID
7 0.0000008703 ADVANCED GLYCATION END PRODUCTS//HMGB1//RAGE
8 0.0000008333 AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM//ENERGY EXPENDITURE//INDIRECT CALORIMETRY
9 0.0000007432 NEUROPEPTIDE Y//GLUCAGON LIKE PEPTIDE 1//GLP 1
10 0.0000006705 ISLET TRANSPLANTATION//PANCREATIC ISLETS//ISLET